Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nonmodulation and essential hypertension.

Norman K Hollenberg1, Gordon H Williams

  • 1Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA. djpagecapo@rics.bwh.harvard.edu

Current Hypertension Reports
|May 5, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic Association of the Renin-Angiotensin-Aldosterone System with hypertension among the Malays and their adaptation to climate change.

PloS one·2026
Same author

UNI-494 treatment improves measures of renal dysfunction and cardiac pathology in male rats receiving L-NAME and angiotensin II.

Physiological reports·2025
Same author

Striatin (STRN): A multifunctional protein in cardiovascular health and cancer progression.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2025
Same author

The renin-angiotensin-aldosterone system and salt sensitivity of blood pressure offer new insights in obesity phenotypes.

Obesity (Silver Spring, Md.)·2025
Same author

Increased Salt-Sensitive Blood Pressure in Women vs Men: Is Relative Hyperaldosteronism the Mechanism?

The Journal of clinical endocrinology and metabolism·2024
Same author

Role of Raptor Gene Variants in Hypertension: Influence on Blood Pressure Independent of Salt Intake in White Population.

Hypertension (Dallas, Tex. : 1979)·2024
Same journal

Neural Control of Tissue Perfusion: Emerging Evidence and Beyond.

Current hypertension reports·2026
Same journal

Correction to: Should Incretin Agonist-Based Drugs be Considered for First Line Antihypertensive Therapy?

Current hypertension reports·2026
Same journal

Intersection of Pediatric Hypertension and Cardiovascular-Kidney-Metabolic Disease.

Current hypertension reports·2026
Same journal

Combined Aldosterone Synthase and SGLT2 Inhibition: A Recipe for Success in CKD with Uncontrolled Blood Pressure?

Current hypertension reports·2026
Same journal

Leveraging the Electronic Health Record to Identify and Manage Resistant Hypertension.

Current hypertension reports·2026
Same journal

Should Incretin Agonist-Based Brugs be Considered for First Line Antihypertensive Therapy?

Current hypertension reports·2026
See all related articles

Nonmodulation, a condition affecting blood pressure regulation, involves impaired kidney and adrenal responses to angiotensin. Angiotensin-converting enzyme inhibition corrects these issues, suggesting genetic links in hypertension.

Area of Science:

  • Nephrology
  • Endocrinology
  • Genetics

Background:

  • Nonmodulation is characterized by disordered angiotensin-dependent control of renal circulation and aldosterone release.
  • This condition leads to impaired sodium handling and salt-sensitive hypertension.

Purpose of the Study:

  • To investigate the underlying mechanisms of nonmodulation and its genetic basis.
  • To explore the role of angiotensinogen gene polymorphisms in nonmodulation.

Main Methods:

  • Analysis of angiotensin-dependent renal and adrenal function.
  • Assessment of salt sensitivity and hypertension.
  • Genetic analysis of renin substrate (angiotensinogen) gene polymorphisms.

Main Results:

Related Experiment Videos

  • Nonmodulation features were corrected by angiotensin-converting enzyme inhibition.
  • Familial factors, including sibling pair concordance, suggest a genetic component.
  • Gene polymorphisms in angiotensinogen were identified in nonmodulators.

    • Conclusions:

    • Nonmodulation is linked to genetic factors, specifically angiotensinogen gene variations.
    • While genetic factors contribute, other genes likely play a role as nonmodulation affects a significant portion of hypertensive patients.